Veradermics
New Haven, CT · Founded 2020 · CIK 0001827635 · Biotech · Public
Topical biopharmaceutical treatments for dermatological conditions
veradermics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $269M
- 6 Form D · May 2026
- 5 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $476,100 | |
| Private capital raised | Form D · SEC | $22,238,328 | |
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $66,567,075 | |
| Private capital raised | Form D · SEC | $134,999,978 | |
| Private capital raised | Form D · SEC | $29,999,997 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2784 | X4 Pharmaceuticals | — | $313M |
| 2785 | Nuvation Bio | — | $275M |
| 2786 | CELL REPROGRAMMING & THERAPEUTICS LLC | — | — |
| 2787 | Veradermics | — | $269M |
| 2788 | Avalyn Pharma | — | $242M |
| 2789 | Zylo Therapeutics Inc. | — | $4.9M |
| 2790 | Arbor Biotechnologies | — | $227M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Amanda Birdsey-BensonDirector
- DOMINIC CARRANOExecutive Officer
- John ChildsDirector
- JOHN CHILDSDirector
- Vladimir CoricDirector
- VLADIMIR CORICDirector
- Timothy DursoDirector · Executive Officer
- TIM DURSOExecutive Officer
- Christopher EklundDirector
- Patrick EnrightDirector
- PATRICK ENRIGHTDirector
- DAVID FRIEDMANDirector
- Jane Grant-KelsDirector
- JANE GRANT-KELSDirector
- MICHAEL GRECOExecutive Officer
- MARK NEUMANNExecutive Officer
- Katarina PanceDirector
- KATARINA PANCEDirector
- Reid WaldmanDirector · Executive Officer
- REID WALDMANDirector · Executive Officer
Patents
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
- Compositions And Methods Of Use For Modified Release Minoxidilapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.